English | Español
Jamie Barrand | Oct 7, 2015

Cellectar receives National Cancer Institute grant
+ Technology/Innovation
Jamie Barrand | Oct 7, 2015

Lilly, Incyte announce positive results of RA treatment study
Jamie Barrand | Oct 7, 2015

Boston Medical Center releases addiction program findings
+ Technology/Innovation
Jamie Barrand | Oct 6, 2015

Medical-cannibis users in safety study saw no rise in ill effects
Jamie Barrand | Oct 6, 2015

Experimental cancer drug shows promise in reducing MS symptoms
Jamie Barrand | Oct 6, 2015

Eagle Pharmaceuticals receives patent for rapid infusion product
Jamie Barrand | Oct 4, 2015

AbbVie to present at Liver Meeting 2015
April Bamburg | Oct 4, 2015

DNA-based vaccine eliminates nearly 50 percent of cervical lesions in clinical trial

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes